Amgen Inc $137.83

up +0.56


27/8/2014 04:42 PM  |  NASDAQ : AMGN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AMGN Trend Analysis - it has underperformed the S&P 500 by 0%

Partner Headlines

  1. Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

    Benzinga
  2. HCP Boosts Of 29 Years Of Dividend Increases

    IBD
  3. The Tech Industry is Vanishing Before Our Eyes

    FoxBusiness
  4. Stocks End With Small Gains; Amgen Shrugs Off Drug Data

    IBD
  5. AMGEN

    IBD
  6. Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

    Benzinga
  7. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD
  8. Cancer 'Cocktail' Passes Test

    IBD
  9. Nasdaq Leads In Quiet Session; Priceline Nears Buy Point

    IBD
  10. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  11. Morning Market Movers

    Benzinga
  12. Benzinga's Top #PreMarket Gainers

    Benzinga
  13. UPDATE: Amgen Announces Phase 3 ASPIRE Trial of Kyprolis Met Primary Endpoint, ...

    Benzinga
  14. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  15. Amgen Price Target Raised by Various Analysts

    Benzinga
  16. Amgen Restructuring Plan, Q2 Earnings Send Stock Up

    IBD
  17. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  18. Amgen To Slash Workforce

    IBD
  19. Indexes End Lower As Russia Sanctions Hit Stocks

    IBD
  20. Stock Futures Show Some Muscle; Merck, Cognex Rising

    IBD
  21. Earnings Scheduled For July 29, 2014

    Benzinga
  22. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  23. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  24. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  25. US Stock Futures Drop Ahead Of Durable Goods Orders Data

    Benzinga
  26. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  27. UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 For the Treatment ...

    Benzinga
  28. Yellen Swats Down Biotech, Social Media Stocks

    FoxBusiness
  29. Morgan Stanley Issues 2015 'Vintage Values' Stock List

    Benzinga
  30. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  31. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  32. Bind Therapeutics

    IBD
  33. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  34. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  35. Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%

    Benzinga
  36. Morning Market Losers

    Benzinga
  37. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  38. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  39. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  40. UPDATE: Morgan Stanley Reiterates On Amgen On New CFO

    Benzinga
  41. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  42. UPDATE: Morgan Stanley Reiterates On Amgen Following AMAGINE-1 Study

    Benzinga
  43. Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and AstraZeneca ...

    GuruFocus
  44. Amgen

    IBD
  45. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  46. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD
  47. Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces ...

    Benzinga
  48. Stocks End Six-Day Win Streak As Techs Sell Off

    IBD
  49. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  50. #PreMarket Primer: Wednesday, April 23: Data From China Takes Some Pressure ...

    Benzinga
Trading Center